← Back
$KALV All transactions

KalVista Pharmaceuticals, Inc.

A

$ Value

$0

Shares

113,920

Price

$0

Filed

Aug 13

Insider

Name

Palleiko Benjamin L

Title

CHIEF EXECUTIVE OFFICER

CIK

0001366244

Roles

Director Officer

Transaction Details

Transaction Date

2025-08-11

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

113,920

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. | 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on November 11, 2025, subject to continued service through each vesting date. | The option vests over a 4 year period: 1/48th on September 11, 2025, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.

Filing Info

Accession No.

0001415889-25-021678

Form Type

4

Issuer CIK

0001348911

Palleiko Benjamin L's History

Date Ticker Type Value
2026-04-17 KALV $193K
2026-04-16 KALV M
2026-04-16 KALV M $0
2025-09-08 KALV $116K
2025-09-06 KALV M
2025-09-06 KALV M $0
2025-08-22 KALV $145K
2025-08-21 KALV M
2025-08-21 KALV M $0
2025-08-18 KALV $58K

Other Insiders at KALV (90d)

Insider Bought Sold Last
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
$193K 2026-04-17
Venrock Healthcare Capital Partners III, L.P. $3.7M 2026-03-26
Piekos Brian
Chief Financial Officer
2026-04-16
Piekos Brian / Sweeny Nicole
Chief Financial Officer
$38K 2026-04-17
Sweeny Nicole
Chief Commercial Officer
2026-04-16
Audhya Paul K.
CHIEF MEDICAL OFFICER
$54K 2026-04-17